Document Detail


Role of gallium arsenide laser irradiation at 890 nm as an adjunctive to anti-tuberculosis drugs in the treatment of pulmonary tuberculosis.
MedLine Citation:
PMID:  12683708     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Tuberculosis is a global emergency with about nine million people developing disease every year. The long duration of treatment has emerged as a major obstacle in the control of tuberculosis. There is a need for development of new drugs and or shortened therapy. METHODS: The present study was carried out to explore whether any benefit could be achieved by the addition of low level energy laser therapy (LLLT) to the conventional anti-tubercular chemotherapy. One-hundred-thirty new sputum smear positive patients of pulmonary tuberculosis were enrolled to evaluate the bio-stimulatory effects of Gallium Arsenide laser irradiation at 890 nm, as an adjuvant therapy. These patients were randomly divided into two groups to receive either LLLT or sham irradiation (control) concomitantly with anti-tuberculosis chemotherpy. RESULTS: The patients treated with semiconductor laser as an adjuvant therapy along with anti-tuberculosis drugs had a faster clearance of tubercle bacilli from the sputum as compared to the control group (P value at :45 days=0.1392, 60 days=0.0117, 75 days=0.00805, 90 days=0.00739). CONCLUSIONS: These findings provide preliminary evidence that low level laser therapy with Gallium Arsenide laser may be a promising adjunctive therapy for patients with tuberculosis. Faster conversion of sputum should prevent the development of resistant mutants.
Authors:
M M Puri; V K Arora
Related Documents :
11941208 - Electroconvulsive therapy in adolescents.
14750048 - Effect of risperidone on prolactinoma--a case report.
16096078 - Are psychodynamic and psychoanalytic therapies effective?: a review of empirical data.
20703348 - Conduct disorder-a sequelae of viral encephalitis.
19193208 - Ip-10, mcp-1, mcp-2, mcp-3, and il-1ra hold promise as biomarkers for infection with m....
16500798 - Adhd in adults: a study of clinical characteristics, impairment and comorbidity.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Indian journal of chest diseases & allied sciences     Volume:  45     ISSN:  0377-9343     ISO Abbreviation:  Indian J Chest Dis Allied Sci     Publication Date:    2003 Jan-Mar
Date Detail:
Created Date:  2003-04-09     Completed Date:  2003-05-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7612044     Medline TA:  Indian J Chest Dis Allied Sci     Country:  India    
Other Details:
Languages:  eng     Pagination:  19-23     Citation Subset:  IM    
Affiliation:
Department of Tuberculosis and Chest Diseases, LRS Institute of Tuberculosis and Allied Diseases, Sri Aurobindo Marg, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antitubercular Agents / administration & dosage
Combined Modality Therapy
Female
Humans
Laser Therapy, Low-Level*
Male
Tuberculosis, Pulmonary / drug therapy,  radiotherapy,  therapy*
Chemical
Reg. No./Substance:
0/Antitubercular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
Next Document:  Pulmonary functions in patients with epidemic dropsy.